US Bancorp DE Sells 323 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

US Bancorp DE decreased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.5% during the 4th quarter, Holdings Channel.com reports. The fund owned 12,469 shares of the biotechnology company’s stock after selling 323 shares during the quarter. US Bancorp DE’s holdings in Axon Enterprise were worth $7,411,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Public Sector Pension Investment Board grew its holdings in Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after acquiring an additional 500 shares during the period. CIBC Asset Management Inc boosted its position in shares of Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after purchasing an additional 895 shares during the last quarter. Axxcess Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the third quarter worth $814,000. Soros Capital Management LLC bought a new stake in Axon Enterprise in the third quarter valued at about $630,000. Finally, Friedenthal Financial lifted its stake in Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after buying an additional 1,231 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $528.28 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market cap of $40.28 billion, a price-to-earnings ratio of 136.51, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The stock’s 50-day moving average is $607.58 and its 200-day moving average is $526.43. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99.

Analyst Ratings Changes

AXON has been the subject of several analyst reports. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Needham & Company LLC restated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price for the company. in a research note on Thursday, February 20th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Insider Activity at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.